U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H11As2N2O4S.2Na.H
Molecular Weight 488.133
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 1
Charge 0

SHOW SMILES / InChI
Structure of NEOARSPHENAMINE DISODIUM

SMILES

[H+].[Na+].[Na+].NC1=CC(=CC=C1[O-])\[As]=[As]\C2=CC=C([O-])C(NCOS[O-])=C2

InChI

InChIKey=KYSHZSXHSFTFGJ-UHFFFAOYSA-L
InChI=1S/C13H14As2N2O4S.2Na/c16-10-5-8(1-3-12(10)18)14-15-9-2-4-13(19)11(6-9)17-7-21-22-20;;/h1-6,17-20H,7,16H2;;/q;2*+1/p-2

HIDE SMILES / InChI
Molecular Formula Na
Molecular Weight 22.9898
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula H
Molecular Weight 1.0079
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula C13H11As2N2O4S
Molecular Weight 441.146
Charge -3
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 1
Optical Activity NONE

Description

Neoarsphenamine and related compounds are sulfhydryl-binding agents which are tolerated by man. A large experience in the employment of this drug and its toxic manifestations exists as a result of its former use as an antisyphilitic agent. Tertiary syphilis was a common cause for mental health conditions. Also known as Neosalvarsan, it superseded Salvarsan due to its lower toxicity. Both arsenicals still carried significant risk of side-effects and were themselves replaced by penicillin in the 1940s. Neoarsphenamine was also used for the treatment of amebic dysentery.

Approval Year

1912
10
PubMed

PubMed

TitleDatePubMed
Renal damage resulting from idiosyncrasy to neoarsphenamine.
1947 Jan

Sample Use Guides

In Vivo Use Guide
Intravenous injections of 0.3 g in the treatment of urinary tract infections and gonorrheal prostatitis
Route of Administration: Intravenous
In Vitro Use Guide
A buffered saline suspension containing approximately 2.5 x 10(7) cells/ml of M. sodonensis was made from a culture growing in log phase. The suspension was divided in half. To one portion neoarsphenamine was added to a concentration of 10(−3) M.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:28:30 GMT 2023
Edited
by admin
on Sat Dec 16 08:28:30 GMT 2023
Record UNII
92LBK3YOIY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NEOARSPHENAMINE DISODIUM
WHO-DD  
Common Name English
METHANOL, (5-((3-AMINO-4-HYDROXYPHENYL)ARSENO)-2-HYDROXYANILINO)-, 1-(HYDROGEN SULFOXYLATE) (ESTER), DISODIUM SALT
Systematic Name English
NEO-ARSOLUIN DISODIUM
Common Name English
NOVARSENOL DISODIUM
Common Name English
Neoarsphenamine disodium [WHO-DD]
Common Name English
SULFOXYLIC ACID, MONO(((5-((3-AMINO-4-HYDROXYPHENYL)DIARSENYL)-2-HYDROXYPHENYL)AMINO)METHYL) ESTER, SODIUM SALT (1:2)
Systematic Name English
SULFOXYLIC ACID, MONO(((5-((3-AMINO-4-HYDROXYPHENYL)DIARSENYL)-2-HYDROXYPHENYL)AMINO)METHYL) ESTER, DISODIUM SALT
Systematic Name English
NEOSALVARSAN DISODIUM
Common Name English
Code System Code Type Description
PUBCHEM
90479688
Created by admin on Sat Dec 16 08:28:30 GMT 2023 , Edited by admin on Sat Dec 16 08:28:30 GMT 2023
PRIMARY
EVMPD
SUB03405MIG
Created by admin on Sat Dec 16 08:28:30 GMT 2023 , Edited by admin on Sat Dec 16 08:28:30 GMT 2023
PRIMARY
SMS_ID
100000085712
Created by admin on Sat Dec 16 08:28:30 GMT 2023 , Edited by admin on Sat Dec 16 08:28:30 GMT 2023
PRIMARY
FDA UNII
92LBK3YOIY
Created by admin on Sat Dec 16 08:28:30 GMT 2023 , Edited by admin on Sat Dec 16 08:28:30 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966